Top compounds associated with response to CLDND2


Feature Type Standardized
Nominal ANOVA
mRNA ZSTK474 CTRPv2 pan-cancer AAC -0.031 0.4
mRNA BRD-K42260513 CTRPv2 pan-cancer AAC 0.045 0.4
mRNA AZD0530 CCLE pan-cancer AAC 0.041 0.4
mRNA KX2-391 CTRPv2 pan-cancer AAC -0.027 0.4
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.028 0.4
mRNA AZD-2281 CTRPv2 pan-cancer AAC -0.028 0.4
mRNA FSC231 CTRPv2 pan-cancer AAC -0.059 0.4
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.029 0.4
mRNA lapatinib CTRPv2 pan-cancer AAC -0.029 0.4
mRNA SJ-172550 CTRPv2 pan-cancer AAC -0.031 0.4
Download CSV